Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

A transformational new pill for treating endometriosis has been approved for use on the NHS across England. The new tablet, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The new drug, called relugolix-estradiol-norethisterone, is a combination pill that blocks specific hormones that contribute to endometriosis, while also providing necessary hormone replacement ...

The combination drug could help around 1,000 women every year in England who suffer from the debilitating condition. | ITV National News ...

Breakthrough for endometriosis sufferers as first-of-its-kind pill to be available on NHS - The daily pill will eliminate the need for injections ...

The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...

Endometriosis affects around 1.5 million women in the UK, causing chronic pain and fatigue. But currently injectable ...